ETON Latest Press Releases

-- November 2, 2026 --

Eton Pharmaceuticals Announces Licensing and Initiation of ET-900 Program Evaluating Mecasermin/IGF-1 for Treatment of Infantile and Epileptic Spasms Globe Newswire 6:50 AM

-- October 29, 2026 --

Eton Pharmaceuticals to Report Third Quarter 2026 Financial Results on Thursday, November 5, 2026 Globe Newswire 6:50 AM

-- October 14, 2026 --

Eton Pharmaceuticals and Aquestive Therapeutics Announce Exclusive U.S. Licensing Agreement for LIBERVANT (diazepam) Buccal Film Globe Newswire 6:50 AM

-- September 28, 2026 --

Eton Pharmaceuticals Announces U.S. Commercial Availability of IMPAVIDO (miltefosine) Capsules Globe Newswire 6:50 AM

-- August 27, 2026 --

Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference Globe Newswire 6:50 AM

-- August 13, 2026 --

Eton Pharmaceuticals Reports Second Quarter 2026 Financial Results Globe Newswire 4:05 PM

-- August 5, 2026 --

Eton Pharmaceuticals Expands Infantile Hemangioma Franchise with Acquisition of U.S. Rights to Late-Stage Product Candidate ASN-001 Globe Newswire 6:50 AM

-- August 3, 2026 --

Eton Pharmaceuticals to Report Second Quarter 2026 Financial Results on Thursday, August 13, 2026 Globe Newswire 6:50 AM

-- July 29, 2026 --

Eton Pharmaceuticals Announces Submission of Prior Approval Supplement to Expand Indication of KHINDIVI (hydrocortisone) Oral Solution Globe Newswire 6:50 AM

Market Data Delayed 15 Minutes